BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tvarijonaviciute A, Zamora C, Ceron JJ, Bravo-Cantero AF, Pardo-Marin L, Valverde S, Lopez-Jornet P. Salivary biomarkers in Alzheimer's disease. Clin Oral Investig 2020;24:3437-44. [PMID: 31989369 DOI: 10.1007/s00784-020-03214-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Kodintsev AN, Kovtun OP, Volkova LI. Saliva Biomarkers in Diagnostics of Early Stages of Alzheimer’s Disease. Neurochem J 2020;14:429-38. [DOI: 10.1134/s1819712420040042] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Campese N, Beatino MF, Del Gamba C, Belli E, Giampietri L, Del Prete E, Galgani A, Vergallo A, Siciliano G, Ceravolo R, Hampel H, Baldacci F. Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer's and other neurodegenerative diseases. Expert Rev Neurother 2021;:1-19. [PMID: 34365867 DOI: 10.1080/14737175.2021.1965879] [Reference Citation Analysis]
3 Saunders S, Ritchie CW, Russ TC, Muniz-terrera G, Milne R. Assessing and disclosing test results for ‘mild cognitive impairment’: the perspective of old age psychiatrists in Scotland. BMC Geriatr 2022;22. [DOI: 10.1186/s12877-021-02693-x] [Reference Citation Analysis]
4 Bălașa AF, Chircov C, Grumezescu AM. Body Fluid Biomarkers for Alzheimer's Disease-An Up-To-Date Overview. Biomedicines 2020;8:E421. [PMID: 33076333 DOI: 10.3390/biomedicines8100421] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Lopez-Jornet P, Felipe CC, Pardo-Marin L, Ceron JJ, Pons-Fuster E, Tvarijonaviciute A. Salivary Biomarkers and Their Correlation with Pain and Stress in Patients with Burning Mouth Syndrome. J Clin Med 2020;9:E929. [PMID: 32231113 DOI: 10.3390/jcm9040929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rastogi S, Sharma V, Bharti PS, Rani K, Modi GP, Nikolajeff F, Kumar S. The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis. Int J Mol Sci 2021;22:E440. [PMID: 33406804 DOI: 10.3390/ijms22010440] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
7 Jia SY, Zhang YL, Sun XY, Yuan C, Zheng SG. Impact of the Glycemic Level on the Salivary Proteome of Middle-Aged and Elderly People With Type 2 Diabetes Mellitus: An Observational Study. Front Mol Biosci 2021;8:790091. [PMID: 34957219 DOI: 10.3389/fmolb.2021.790091] [Reference Citation Analysis]
8 Goldoni R, Dolci C, Boccalari E, Inchingolo F, Paghi A, Strambini L, Galimberti D, Tartaglia GM. Salivary biomarkers of neurodegenerative and demyelinating diseases and biosensors for their detection. Ageing Research Reviews 2022. [DOI: 10.1016/j.arr.2022.101587] [Reference Citation Analysis]
9 Karki HP, Jang Y, Jung J, Oh J. Advances in the development paradigm of biosample-based biosensors for early ultrasensitive detection of alzheimer's disease. J Nanobiotechnology 2021;19:72. [PMID: 33750392 DOI: 10.1186/s12951-021-00814-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Katsipis G, Tzekaki EE, Tsolaki M, Pantazaki AA. Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis. J Neuroimmunol 2021;361:577744. [PMID: 34655990 DOI: 10.1016/j.jneuroim.2021.577744] [Reference Citation Analysis]